These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 25875796)

  • 1. The proteome of postsurgical pancreatic juice.
    Marchegiani G; Paulo JA; Sahora K; Fernández-Del Castillo C
    Pancreas; 2015 May; 44(4):574-82. PubMed ID: 25875796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic analysis identifies MMP-9, DJ-1 and A1BG as overexpressed proteins in pancreatic juice from pancreatic ductal adenocarcinoma patients.
    Tian M; Cui YZ; Song GH; Zong MJ; Zhou XY; Chen Y; Han JX
    BMC Cancer; 2008 Aug; 8():241. PubMed ID: 18706098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein I as a biomarker for pancreatic ductal adenocarcinoma by protein biochip technology.
    Rosty C; Christa L; Kuzdzal S; Baldwin WM; Zahurak ML; Carnot F; Chan DW; Canto M; Lillemoe KD; Cameron JL; Yeo CJ; Hruban RH; Goggins M
    Cancer Res; 2002 Mar; 62(6):1868-75. PubMed ID: 11912167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a temporary intraoperative mesentericoportal shunt for pancreatic resection for locally advanced pancreatic cancer with portal vein occlusion and portal hypertension.
    Bachellier P; Rosso E; Fuchshuber P; Addeo P; David P; Oussoultzoglou E; Lucescu I
    Surgery; 2014 Mar; 155(3):449-56. PubMed ID: 24462078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The effect of blood-pancreatic juice barrier on 5-fluorouracil in post-pancreatoduodenectomy patients].
    Zhao Y; Liao Q; Zhu Z; Fu Q; Cai L; Zhu Y
    Zhonghua Wai Ke Za Zhi; 1999 Mar; 37(3):144-5. PubMed ID: 11829804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neoadjuvant therapy and biliary decompression lower biliary and pancreatic juice vascular endothelial growth factor levels in patients with periampullary adenocarcinoma.
    Berger AC; Watson JC; Ross EA; Zalatoris A; Hoffman JP
    Am Surg; 2004 Feb; 70(2):169-73; discussion 173-4. PubMed ID: 15011922
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression analyses in preoperative pancreatic juice samples of pancreatic ductal adenocarcinoma.
    Sadakari Y; Ohtsuka T; Ohuchida K; Tsutsumi K; Takahata S; Nakamura M; Mizumoto K; Tanaka M
    JOP; 2010 Nov; 11(6):587-92. PubMed ID: 21068491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomic Analysis of Cell Lines and Primary Tumors in Pancreatic Cancer Identifies Proteins Expressed Only In Vitro and Only In Vivo.
    Coleman O; Henry M; O'Neill F; Roche S; Swan N; Geoghegan J; Conlon K; McVey G; Moriarty M; Meleady P; Clynes M
    Pancreas; 2020 Sep; 49(8):1109-1116. PubMed ID: 32833945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics analysis of bodily fluids in pancreatic cancer.
    Pan S; Brentnall TA; Chen R
    Proteomics; 2015 Aug; 15(15):2705-15. PubMed ID: 25780901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic analysis of pancreatic ductal adenocarcinoma cells reveals metabolic alterations.
    Zhou W; Capello M; Fredolini C; Piemonti L; Liotta LA; Novelli F; Petricoin EF
    J Proteome Res; 2011 Apr; 10(4):1944-52. PubMed ID: 21309613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The treatment of pancreatic cancer.
    Yeo CJ; Cameron JL
    Ann Chir Gynaecol; 2000; 89(3):225-33. PubMed ID: 11079793
    [No Abstract]   [Full Text] [Related]  

  • 12. Analysis of the pancreatic tumor progression by a quantitative proteomic approach and immunhistochemical validation.
    Sitek B; Sipos B; Alkatout I; Poschmann G; Stephan C; Schulenborg T; Marcus K; Lüttges J; Dittert DD; Baretton G; Schmiegel W; Hahn SA; Klöppel G; Meyer HE; Stühler K
    J Proteome Res; 2009 Apr; 8(4):1647-56. PubMed ID: 19714807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poorly differentiated resectable pancreatic cancer: is upfront resection worthwhile?
    Crippa S; Partelli S; Zamboni G; Barugola G; Capelli P; Inama M; Bassi C; Pederzoli P; Falconi M
    Surgery; 2012 Sep; 152(3 Suppl 1):S112-9. PubMed ID: 22766365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term survival (5-20 years) after pancreatectomy for pancreatic ductal adenocarcinoma: a series of 30 patients collected from 3 institutions.
    Adham M; Jaeck D; Le Borgne J; Oussoultzouglou E; Chenard-Neu MP; Mosnier JF; Scoazec JY; Mornex F; Partensky C
    Pancreas; 2008 Nov; 37(4):352-7. PubMed ID: 18665012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total laparoscopic pancreaticoduodenectomy for pancreatic ductal adenocarcinoma: oncologic advantages over open approaches?
    Croome KP; Farnell MB; Que FG; Reid-Lombardo KM; Truty MJ; Nagorney DM; Kendrick ML
    Ann Surg; 2014 Oct; 260(4):633-8; discussion 638-40. PubMed ID: 25203880
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neoadjuvant chemo- or chemo-radiation-therapy of pancreatic ductal adenocarcinoma differentially shift ECM composition, complement activation, energy metabolism and ribosomal proteins of the residual tumor mass.
    Stillger MN; Kurowski K; Bronsert P; Brombacher E; Kreutz C; Werner M; Tang L; Timme-Bronsert S; Schilling O
    Int J Cancer; 2024 Jun; 154(12):2162-2175. PubMed ID: 38353498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative Proteomic Analysis of Differentially Expressed Protein Profiles Involved in Pancreatic Ductal Adenocarcinoma.
    Kuo KK; Kuo CJ; Chiu CY; Liang SS; Huang CH; Chi SW; Tsai KB; Chen CY; Hsi E; Cheng KH; Chiou SH
    Pancreas; 2016 Jan; 45(1):71-83. PubMed ID: 26262590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preoperative chemoradiation in adenocarcinoma of the pancreas. A single centre experience advocating a new treatment strategy.
    Golcher H; Brunner T; Grabenbauer G; Merkel S; Papadopoulos T; Hohenberger W; Meyer T
    Eur J Surg Oncol; 2008 Jul; 34(7):756-64. PubMed ID: 18191528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrated proteomic profiling of cell line conditioned media and pancreatic juice for the identification of pancreatic cancer biomarkers.
    Makawita S; Smith C; Batruch I; Zheng Y; Rückert F; Grützmann R; Pilarsky C; Gallinger S; Diamandis EP
    Mol Cell Proteomics; 2011 Oct; 10(10):M111.008599. PubMed ID: 21653254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer.
    Kosuge T; Kiuchi T; Mukai K; Kakizoe T;
    Jpn J Clin Oncol; 2006 Mar; 36(3):159-65. PubMed ID: 16490736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.